The Future of Genomics and Targeted TherapiesVideo Categories: 2018 AONN Midyear
Dr Andrey Antov muses on the evolution of genomics and how it could potentially impact targeted therapies and cancer care.
Dr. Alex Adjei offers options to make cancer care more cost-effective, such as selecting only patients who will benefit from treatment and continuing to offer treatments that will allow patients to remain in the workforce.
Dr. Michaelis discusses what approaches she takes for PV patients with unmet clinical needs such as recurrent thrombosis or hemorrhage. Supported through funding from Incyte